About Allodiagnostic
Allodiagnostic is a company based in France founded in 2004 was acquired by Andera Partners in September 2017. It operates as a Marketplace for Real Estate Diagnostics. Allodiagnostic offers products and services including Diagnostic de Performance Énergétique (DPE), Amiante Diagnosis, Audit Énergétique, and État des Risques et Pollutions (ERP).
- Headquarter France
-
Sectors
Real Estate & Construction
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sas Adx Groupe
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Andera Partners
(Sep 12, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Allodiagnostic
Allodiagnostic offers a comprehensive portfolio of products and services, including Diagnostic de Performance Énergétique (DPE), Amiante Diagnosis, Audit Énergétique, and État des Risques et Pollutions (ERP).
Energy performance diagnostics are conducted to assess the energy efficiency of properties for sale or rent.
Asbestos detection is performed before works or demolition to ensure safety compliance.
Energy audits are carried out to provide insights into building energy efficiency and renovation needs.
Risk and pollution assessments are provided to inform property owners of environmental hazards.
Funding Insights of Allodiagnostic
Detailed funding history for Allodiagnostic
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Allodiagnostic
Allodiagnostic has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Andera Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Capital is provided to firms for growth, buyouts, and acquisitions.
|
Locked | Locked | Locked |
Investor details for Allodiagnostic
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Allodiagnostic
Investment portfolio details for Allodiagnostic
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Allodiagnostic
Detailed financials for Allodiagnostic
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Allodiagnostic Comparisons
Peer comparison for Allodiagnostic
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Allodiagnostic
Detailed competitors of Allodiagnostic
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Allodiagnostic
Complete news archive for Allodiagnostic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Allodiagnostic
Allodiagnostic was founded in 2004.
Allodiagnostic is headquartered in France.
Comprehensive real estate diagnostic services are offered by Allodiagnostic, operating as the first marketplace for property diagnostics in France. Services cover mandatory diagnostics for property sales and rentals, including energy performance, asbestos, lead, electrical, gas, and environmental risk assessments. The company serves both individual and professional clients across various sectors, with a national network of certified technicians ensuring rapid intervention in cities like Paris, Lyon, Marseille, and Toulouse. Solutions also extend to energy audits and technical diagnostics for building renovations, securing real estate transactions with detailed assessments.
Allodiagnostic offers Diagnostic de Performance Énergétique (DPE), Amiante Diagnosis, Audit Énergétique, and État des Risques et Pollutions (ERP).
Allodiagnostic has 1 investor. Key investors include Andera Partners.